首页 > 最新文献

Journal of Hepatitis Research最新文献

英文 中文
The Glycodiversity of HCV E2 Glycoprotein-Specific Antibodies as a Signature of Hepatic Damage and Virotherapy Efficacy HCV E2糖蛋白特异性抗体的糖多样性作为肝损伤和病毒治疗效果的标志
Pub Date : 2022-04-11 DOI: 10.26420/jhepatres.2022.1046
K. O, J. J., S. B, G. J.
The HCV E2 glycoprotein-specific Abs (E2-Ab) is an important factor in the host resistance to hepatitis C virus (HCV) infection. There is evidence that the E2-Ab sialylation is associated with liver damage and virotherapy efficacy. The aim of this study was to further profile the E2-Ab glycosylation. The fucosylation and sialylation of E2-Ab in one hundred six (HCV)-infected patients were tested using the lectin-based ELISA platform. Data were analyzed by the stage of hepatic fibrosis, HCV genotype and the response to IF-RBV virotherapy. The changes in the E2–Ab glycosylation were also evaluated by the receiver operator characteristic curve (ROC) and multiple regression analysis. The E2-Ab reactivity to fucose-specific Aleuria aurantia lectin (AAL) and sialo-specific Sambucus nigra agglutinin (SNA) was decreased in the advanced stages of liver fibrosis. The SNA binding analysis was more informative in the discrimination of patients with advanced fibrosis compared to those with earlier fibrosis stages or no fibrosis group. No significant correlation between the reactivities of SNA and AAL lectins was established irrespective of HCV genotype. The patients infected with HCV 3a genotype showed an increased E2-Ab fucosylation, a lower E2-SNA/E2-AAL ratio and a better response to virotherapy. The association of the E2-SNA/E2-AAL ratio with virotherapy outcome was observed in patients infected with HCV 1b genotype. A better response to IF-RBV therapy was found in patients with a higher fucosylated E2 Abs and a lower E2-SNA/E2-AAL ratio. Thus the significance of E2 antibodies in the course of HCV hepatitis was demonstrated to be dependent on their glycosylation, the sialylation/fucosylation ratio, as well as on HCV genotype.
HCV E2糖蛋白特异性抗体(E2- ab)是宿主抵抗丙型肝炎病毒(HCV)感染的重要因素。有证据表明E2-Ab唾液化与肝损伤和病毒治疗效果有关。本研究的目的是进一步分析E2-Ab糖基化。采用基于凝集素的ELISA平台检测了106例HCV感染患者E2-Ab的聚焦化和唾液化。数据通过肝纤维化分期、HCV基因型和对IF-RBV病毒治疗的反应进行分析。采用受试者特征曲线(ROC)和多元回归分析评价E2-Ab糖基化的变化。E2-Ab对病灶特异性金黄色念珠菌凝集素(AAL)和唾液特异性黑Sambucus nigra凝集素(SNA)的反应性在肝纤维化晚期降低。与早期纤维化或无纤维化组相比,SNA结合分析在区分晚期纤维化患者方面提供了更多信息。无论HCV基因型如何,SNA和AAL凝集素的反应性均无显著相关性。感染HCV 3a基因型的患者E2-Ab集中化增加,E2-SNA/E2-AAL比值降低,对病毒治疗的反应更好。在HCV 1b基因型感染的患者中观察到E2-SNA/E2-AAL比值与病毒治疗结果的相关性。研究发现,E2抗体高度集中、E2- sna /E2- aal比值较低的患者对IF-RBV治疗的反应更好。因此,E2抗体在HCV肝炎病程中的意义取决于其糖基化、唾液化/聚焦化比率以及HCV基因型。
{"title":"The Glycodiversity of HCV E2 Glycoprotein-Specific Antibodies as a Signature of Hepatic Damage and Virotherapy Efficacy","authors":"K. O, J. J., S. B, G. J.","doi":"10.26420/jhepatres.2022.1046","DOIUrl":"https://doi.org/10.26420/jhepatres.2022.1046","url":null,"abstract":"The HCV E2 glycoprotein-specific Abs (E2-Ab) is an important factor in the host resistance to hepatitis C virus (HCV) infection. There is evidence that the E2-Ab sialylation is associated with liver damage and virotherapy efficacy. The aim of this study was to further profile the E2-Ab glycosylation. The fucosylation and sialylation of E2-Ab in one hundred six (HCV)-infected patients were tested using the lectin-based ELISA platform. Data were analyzed by the stage of hepatic fibrosis, HCV genotype and the response to IF-RBV virotherapy. The changes in the E2–Ab glycosylation were also evaluated by the receiver operator characteristic curve (ROC) and multiple regression analysis. The E2-Ab reactivity to fucose-specific Aleuria aurantia lectin (AAL) and sialo-specific Sambucus nigra agglutinin (SNA) was decreased in the advanced stages of liver fibrosis. The SNA binding analysis was more informative in the discrimination of patients with advanced fibrosis compared to those with earlier fibrosis stages or no fibrosis group. No significant correlation between the reactivities of SNA and AAL lectins was established irrespective of HCV genotype. The patients infected with HCV 3a genotype showed an increased E2-Ab fucosylation, a lower E2-SNA/E2-AAL ratio and a better response to virotherapy. The association of the E2-SNA/E2-AAL ratio with virotherapy outcome was observed in patients infected with HCV 1b genotype. A better response to IF-RBV therapy was found in patients with a higher fucosylated E2 Abs and a lower E2-SNA/E2-AAL ratio. Thus the significance of E2 antibodies in the course of HCV hepatitis was demonstrated to be dependent on their glycosylation, the sialylation/fucosylation ratio, as well as on HCV genotype.","PeriodicalId":269194,"journal":{"name":"Journal of Hepatitis Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132721278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sialylation of HCV E2 Glycoprotein-Specific and Natural Anti-Glycan (TF, αGal) Antibodies as Signatures of Liver Damage HCV E2糖蛋白特异性和天然抗聚糖(TF, αGal)抗体的唾液酰化作为肝损伤的标志
Pub Date : 2021-06-01 DOI: 10.26420/jhepatres.2021.1043
O. Kurtenkov, J. Jakovleva, B. Sergejev, J. Geller
The E2 glycoprotein is the target of broadly neutralizing antibodies against Hepatitis C Virus (HCV). There is evidence that the HCV E2-specific antibody glycosylation profile is associated with hepatic fibrosis progression. The main aim of this study was to compare the sialylation of E2-specific and naturally occurring antiglycan Abs to determine whether their combination could be beneficial for the non-invasive evaluation of hepatic damage. Fifty-eight patients with various stages of hepatic fibrosis or without were tested. The sialylation of HCV E2 glycoprotein-specific antibodies (E2-Abs), the Thomsen-Friedenreich antigen- and αGal glycotope-specific antibodies (TF-Abs, αGal-Abs) was analysed using the ELISA platform. The level of IgG Abs and their reactivity to Sialospecific Sambucus Nigra Lectin (SNA) were determined and changes in Abs sialylation were analysed based on the stage of liver fibrosis, HCV genotype and antiviral therapy efficacy. The late stage of liver Fibrosis (F4) was characterized by dramatically decreased E2-Ab SNA reactivity unlike stages with no fibrosis (P=0.003) and stages F1–F3 (P=0.0007). In contrast, antiglycan Abs showed an increased sialylation. In multiple regression analysis, the combination of E2 and TF-Abs sialylation patterns gave a significant advantage in assessing liver damage. A high rate of discrimination between F0 and F4 stages of fibrosis as well as between F1–F3 and F4 was obtained (ACC=0.948 and ACC=0.90, respectively). Thus, the combined analysis of disease-specific and natural Abs sialylation can remarkably enhance the clinical value of the approach in the non-invasive evaluation of hepatic damage.
E2糖蛋白是抗丙型肝炎病毒(HCV)广泛中和抗体的靶标。有证据表明,HCV e2特异性抗体糖基化谱与肝纤维化进展有关。本研究的主要目的是比较e2特异性和天然存在的抗糖多糖抗体的唾液化,以确定它们的组合是否有益于肝损伤的非侵入性评估。对58例不同阶段肝纤维化或无肝纤维化的患者进行了检测。采用ELISA平台分析HCV E2糖蛋白特异性抗体(E2- abs)、Thomsen-Friedenreich抗原和αGal糖基特异性抗体(TF-Abs、αGal- abs)的唾液酰化水平。根据肝纤维化分期、HCV基因型及抗病毒治疗效果,测定血清IgG抗体水平及对唾液特异性黑参凝集素(SNA)的反应性,分析抗体唾液化水平的变化。晚期肝纤维化(F4)与无纤维化期(P=0.003)和F1-F3期(P=0.0007)不同,E2-Ab SNA反应性显著降低。相反,抗多糖抗体显示唾液化增加。在多元回归分析中,E2和TF-Abs唾液化模式的结合在评估肝损伤方面具有显著优势。F0期和F4期以及F1-F3期和F4期的鉴别率较高(ACC=0.948, ACC=0.90)。因此,结合疾病特异性和天然抗体唾液化分析,可以显著提高该方法在无创肝损害评估中的临床价值。
{"title":"Sialylation of HCV E2 Glycoprotein-Specific and Natural Anti-Glycan (TF, αGal) Antibodies as Signatures of Liver Damage","authors":"O. Kurtenkov, J. Jakovleva, B. Sergejev, J. Geller","doi":"10.26420/jhepatres.2021.1043","DOIUrl":"https://doi.org/10.26420/jhepatres.2021.1043","url":null,"abstract":"The E2 glycoprotein is the target of broadly neutralizing antibodies against Hepatitis C Virus (HCV). There is evidence that the HCV E2-specific antibody glycosylation profile is associated with hepatic fibrosis progression. The main aim of this study was to compare the sialylation of E2-specific and naturally occurring antiglycan Abs to determine whether their combination could be beneficial for the non-invasive evaluation of hepatic damage. Fifty-eight patients with various stages of hepatic fibrosis or without were tested. The sialylation of HCV E2 glycoprotein-specific antibodies (E2-Abs), the Thomsen-Friedenreich antigen- and αGal glycotope-specific antibodies (TF-Abs, αGal-Abs) was analysed using the ELISA platform. The level of IgG Abs and their reactivity to Sialospecific Sambucus Nigra Lectin (SNA) were determined and changes in Abs sialylation were analysed based on the stage of liver fibrosis, HCV genotype and antiviral therapy efficacy. The late stage of liver Fibrosis (F4) was characterized by dramatically decreased E2-Ab SNA reactivity unlike stages with no fibrosis (P=0.003) and stages F1–F3 (P=0.0007). In contrast, antiglycan Abs showed an increased sialylation. In multiple regression analysis, the combination of E2 and TF-Abs sialylation patterns gave a significant advantage in assessing liver damage. A high rate of discrimination between F0 and F4 stages of fibrosis as well as between F1–F3 and F4 was obtained (ACC=0.948 and ACC=0.90, respectively). Thus, the combined analysis of disease-specific and natural Abs sialylation can remarkably enhance the clinical value of the approach in the non-invasive evaluation of hepatic damage.","PeriodicalId":269194,"journal":{"name":"Journal of Hepatitis Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116317861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, Attitude and Practice of Hepatitis B among Informal Caregivers at Ndola Teaching Hospital 恩多拉教学医院非正规护理人员乙型肝炎知识、态度与实践
Pub Date : 2021-05-11 DOI: 10.26420/jhepatres.2021.1042
Killard Sc
Introduction: Hepatitis B is a highly contagious infection. It is 50 to 100 times more infectious than HIV. It is the world’s most common liver infection, which is caused by a DNA-virus, the hepatitis B virus and is transmitted between people through blood, semen, vaginal fluids and mucous membranes. Basic knowledge about hepatitis B is necessary; with more knowledge people take preventive actions against hepatitis B, such as using stick proof cannulas. The general objective of this study was to assess the knowledge, attitude and practice of HBV infection among informal caregivers at Ndola Teaching Hospital, Ndola, Zambia. Method: A Cross sectional study was carried out at Ndola Teaching Hospital from June 2020 to September 2020. Systematic random sampling was used using questionnaire based interviews to consenting informal caregivers above the age of 18 years who were waiting for their patients in Gynecological ward, surgical wards and internal medicine wards. Results: A total number of 165 informal caregivers at Ndola Teaching Hospital were interviewed using a pretested questionnaire. The highest age group (44.2%) interviewed was between 25 to 34 years of age. The majority of informal caregivers (52.1%) went up to secondary education level and 63.0% of the informal caregivers were females. Most informal caregivers (53.3%) only had an average knowledge about hepatitis B infection. Informal caregiver’s education level was directly associated with the level of knowledge about Hepatitis B (p-value<0.001). Majority (87.3%) of the informal caregivers had good attitude towards hepatitis B. There was a direct association (p value <0.001) between informal caregiver’s knowledge on hepatitis B with their attitude. All the informal caregivers (100%) had bad practices on Hepatitis B and majority of the respondents 159 (96.4%) were not vaccinated only 6 (3.6%) were vaccinated against HBV. Conclusion: Hepatitis B is a major health problem globally casting an enormous burden on the health-care system a major source of patient’s misery. This illness or disease is preventable. In this study, the majority of the participants had good attitudes making knowledge as the main determinant of their practices. Therefore, primary prevention approach be taken by extensively and frequently teaching all informal care givers in all hospitals and clinics on how to protect themselves from the disease. Pictorial Posters depicting the proper way of handling patients by informal caregivers be displayed in health centers (wards and OPDs).
乙型肝炎是一种高度传染性的传染病。它的传染性是艾滋病毒的50到100倍。它是世界上最常见的肝脏感染,由一种dna病毒,即乙型肝炎病毒引起,并通过血液、精液、阴道液和粘膜在人与人之间传播。有必要了解乙型肝炎的基本知识;有了更多的知识,人们就会采取预防乙型肝炎的行动,例如使用防棍插管。本研究的总体目的是评估赞比亚恩多拉教学医院非正式护理人员对HBV感染的知识、态度和行为。方法:于2020年6月至2020年9月在恩多拉教学医院进行横断面研究。采用系统随机抽样的方法,采用问卷访谈法对在妇科、外科和内科病房等候患者的18岁以上自愿的非正式护理人员进行调查。结果:采用预测问卷对恩多拉教学医院的165名非正式护理人员进行了访谈。受访的最高年龄组(44.2%)为25至34岁。其中,中等以上文化程度者占52.1%,女性占63.0%。大多数非正式护理人员(53.3%)对乙型肝炎感染的了解仅为平均水平。非正式照顾者的受教育程度与乙型肝炎知识水平直接相关(p值<0.001)。绝大多数(87.3%)的非正式照护者对乙肝的态度良好。非正式照护者对乙肝的认知程度与其态度有直接关系(p值<0.001)。所有非正式护理人员(100%)对乙型肝炎有不良做法,大多数答复者159人(96.4%)未接种乙肝疫苗,只有6人(3.6%)接种了乙肝疫苗。结论:乙型肝炎是一个全球性的重大卫生问题,给卫生保健系统造成巨大负担,是患者痛苦的主要来源。这种疾病是可以预防的。在这项研究中,大多数参与者都有良好的态度,使知识成为他们实践的主要决定因素。因此,应采取初级预防措施,广泛和经常地向所有医院和诊所的所有非正式护理人员传授如何保护自己免受这种疾病的侵害。在保健中心(病房和门诊)张贴描绘非正式护理人员处理病人的正确方式的图画海报。
{"title":"Knowledge, Attitude and Practice of Hepatitis B among Informal Caregivers at Ndola Teaching Hospital","authors":"Killard Sc","doi":"10.26420/jhepatres.2021.1042","DOIUrl":"https://doi.org/10.26420/jhepatres.2021.1042","url":null,"abstract":"Introduction: Hepatitis B is a highly contagious infection. It is 50 to 100 times more infectious than HIV. It is the world’s most common liver infection, which is caused by a DNA-virus, the hepatitis B virus and is transmitted between people through blood, semen, vaginal fluids and mucous membranes. Basic knowledge about hepatitis B is necessary; with more knowledge people take preventive actions against hepatitis B, such as using stick proof cannulas. The general objective of this study was to assess the knowledge, attitude and practice of HBV infection among informal caregivers at Ndola Teaching Hospital, Ndola, Zambia. Method: A Cross sectional study was carried out at Ndola Teaching Hospital from June 2020 to September 2020. Systematic random sampling was used using questionnaire based interviews to consenting informal caregivers above the age of 18 years who were waiting for their patients in Gynecological ward, surgical wards and internal medicine wards. Results: A total number of 165 informal caregivers at Ndola Teaching Hospital were interviewed using a pretested questionnaire. The highest age group (44.2%) interviewed was between 25 to 34 years of age. The majority of informal caregivers (52.1%) went up to secondary education level and 63.0% of the informal caregivers were females. Most informal caregivers (53.3%) only had an average knowledge about hepatitis B infection. Informal caregiver’s education level was directly associated with the level of knowledge about Hepatitis B (p-value<0.001). Majority (87.3%) of the informal caregivers had good attitude towards hepatitis B. There was a direct association (p value <0.001) between informal caregiver’s knowledge on hepatitis B with their attitude. All the informal caregivers (100%) had bad practices on Hepatitis B and majority of the respondents 159 (96.4%) were not vaccinated only 6 (3.6%) were vaccinated against HBV. Conclusion: Hepatitis B is a major health problem globally casting an enormous burden on the health-care system a major source of patient’s misery. This illness or disease is preventable. In this study, the majority of the participants had good attitudes making knowledge as the main determinant of their practices. Therefore, primary prevention approach be taken by extensively and frequently teaching all informal care givers in all hospitals and clinics on how to protect themselves from the disease. Pictorial Posters depicting the proper way of handling patients by informal caregivers be displayed in health centers (wards and OPDs).","PeriodicalId":269194,"journal":{"name":"Journal of Hepatitis Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127118236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis B Virus Infection among Prison Inmates in Borno State: Determination of Prevalence of Surface Antigen (HBsAg) and Possible Risk Factors of Disease 博尔诺州监狱囚犯中乙型肝炎病毒感染:表面抗原(HBsAg)流行率的测定和疾病可能的危险因素
Pub Date : 2021-05-10 DOI: 10.26420/jhepatres.2021.1041
S. Lawan, Elyuguda Ad, Gimba Sn, H. Sabo, Dadile Hm, Nigeria Midwifery Damaturu
An epidemiological study on hepatitis B virus infection among prison inmates in Borno state, Nigeria, was carried out using a questionnaire survey to determine the possible risk factors of the disease and serological method [using an Enzyme Linked Immunosorbent Assay (ELISA)] to determine the prevalence of hepatitis B surface antigen (HBsAg) among the inmates. The study was conducted in correctional facilities in Maiduguri, Biu and Bama local government area of Borno State. Out of a total of 300 sera tested, 49 (16.3%) had detectable ELISA antibody to HBsAg. A significant difference (p<0.001) in seroprevalence of HBsAg among inmates of different educational qualifications was observed and those with higher education had the highest prevalence (20.9%). Although there was no significant difference in prevalence of HBsAg among the different age groups, the age group 60-69 years had the highest infection rate (33.3%). Homosexuality and duration of stay in prison are shown to be significantly associated with HBsAg infection (P<0.05) among inmates. A significant gender difference was noted among inmates with the males (16.1%) having higher prevalence when compared with females (20.0%). Analysis of spatial distribution of prevalence of HBsAg showed that Maiduguri prison had (20.5%), followed by Biu prison (12.7%) and Bama prison (6.7%) and there was significant difference (P<0.05) in prevalence between prisons. There was no significant (P>0.05) association of prevalence of HBsAg with marital status or occupation of prison inmates. In conclusion, hepatitis b virus infection was found to be prevalent among prison inmates in Borno state with homosexuality and duration of stay in prison as risk factors.
对尼日利亚博尔诺州监狱囚犯中乙型肝炎病毒感染进行了流行病学研究,采用问卷调查确定该疾病的可能危险因素,并采用血清学方法[使用酶联免疫吸附试验(ELISA)]确定囚犯中乙型肝炎表面抗原(HBsAg)的流行率。这项研究是在博尔诺州迈杜古里、比乌和巴马地方政府地区的惩教设施中进行的。在总共300份检测的血清中,49份(16.3%)检测到HBsAg的ELISA抗体。监狱在押人员HBsAg患病率与婚姻状况、职业有显著性差异(p0.05)。最后,发现乙型肝炎病毒感染在博尔诺州的监狱囚犯中很普遍,同性恋和服刑时间是危险因素。
{"title":"Hepatitis B Virus Infection among Prison Inmates in Borno State: Determination of Prevalence of Surface Antigen (HBsAg) and Possible Risk Factors of Disease","authors":"S. Lawan, Elyuguda Ad, Gimba Sn, H. Sabo, Dadile Hm, Nigeria Midwifery Damaturu","doi":"10.26420/jhepatres.2021.1041","DOIUrl":"https://doi.org/10.26420/jhepatres.2021.1041","url":null,"abstract":"An epidemiological study on hepatitis B virus infection among prison inmates in Borno state, Nigeria, was carried out using a questionnaire survey to determine the possible risk factors of the disease and serological method [using an Enzyme Linked Immunosorbent Assay (ELISA)] to determine the prevalence of hepatitis B surface antigen (HBsAg) among the inmates. The study was conducted in correctional facilities in Maiduguri, Biu and Bama local government area of Borno State. Out of a total of 300 sera tested, 49 (16.3%) had detectable ELISA antibody to HBsAg. A significant difference (p<0.001) in seroprevalence of HBsAg among inmates of different educational qualifications was observed and those with higher education had the highest prevalence (20.9%). Although there was no significant difference in prevalence of HBsAg among the different age groups, the age group 60-69 years had the highest infection rate (33.3%). Homosexuality and duration of stay in prison are shown to be significantly associated with HBsAg infection (P<0.05) among inmates. A significant gender difference was noted among inmates with the males (16.1%) having higher prevalence when compared with females (20.0%). Analysis of spatial distribution of prevalence of HBsAg showed that Maiduguri prison had (20.5%), followed by Biu prison (12.7%) and Bama prison (6.7%) and there was significant difference (P<0.05) in prevalence between prisons. There was no significant (P>0.05) association of prevalence of HBsAg with marital status or occupation of prison inmates. In conclusion, hepatitis b virus infection was found to be prevalent among prison inmates in Borno state with homosexuality and duration of stay in prison as risk factors.","PeriodicalId":269194,"journal":{"name":"Journal of Hepatitis Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131573130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Hepatitis Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1